Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Pacira BioSciences Stock News

PCRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$24.74

0.512.10%

At close: -

$24.74

0.000.00%

After Hours: 4:03 PM EDT

Pacira BioSciences (PCRX) Forecast

News

Earnings Pacira BioSciences (PCRX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Pacira BioSciences Stock News | NASDAQ:PCRX | Benzinga

Get the latest news on Pacira BioSciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Pacira BioSciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, June 11, 2025

Pacira BioSciences Announces Phase 1 Data Sho...
Benzinga Newsdesk

Thursday, May 15, 2025

Pacira Biosciences: New Preliminary Data Sugg...
Benzinga Newsdesk

Friday, May 09, 2025

Where Pacira BioSciences Stands With Analysts
Benzinga Insights
Needham Maintains Buy on Pacira BioSciences, ...
Benzinga Newsdesk

Thursday, May 08, 2025

Pacira BioSciences Affirms FY2025 Sales Guida...
Benzinga Newsdesk
Pacira BioSciences Q1 Adj. EPS $0.62 Beats $0...
Benzinga Newsdesk
Earnings Scheduled For May 8, 2025
Benzinga Insights

Wednesday, May 07, 2025

Preview: Pacira BioSciences's Earnings
Benzinga Insights

Tuesday, May 06, 2025

Pacira BioSciences Announces It Will Present ...
Benzinga Newsdesk

Friday, May 02, 2025

Pacira BioSciences To Present Findings From P...
Benzinga Newsdesk

Monday, April 28, 2025

Pacira BioSciences Announces 2-Yr Data On PCR...
Benzinga Newsdesk

Tuesday, April 22, 2025

Pacira BioSciences To Present 104-Week Data O...
Benzinga Newsdesk

Monday, April 21, 2025

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
Avi Kapoor

Thursday, April 17, 2025

Pacira BioSciences Announces $300M Share Repu...
Benzinga Newsdesk

Tuesday, April 08, 2025

Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps
Vandana Singh
Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Forecasting The Future: 8 Analyst Projections For Pacira BioSciences
Benzinga Insights
Pacira BioSciences shares are trading higher ...
Benzinga Newsdesk
Needham Reiterates Buy on Pacira BioSciences,...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Pacira B...
Benzinga Newsdesk

Monday, April 07, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Pacira BioSciences shares are trading higher ...
Benzinga Newsdesk
Pacira BioSciences Settles Litigations With F...
Benzinga Newsdesk

Thursday, April 03, 2025

Pacira BioSciences Announces Dosing Of First ...
Benzinga Newsdesk

Friday, February 28, 2025

Barclays Maintains Overweight on Pacira BioSc...
Benzinga Newsdesk
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 7 Analysts
Benzinga Insights
Needham Maintains Buy on Pacira BioSciences, ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Pacira B...
Benzinga Newsdesk

Thursday, February 27, 2025

Pacira BioSciences Acquires 81% Remaining Equ...
Benzinga Newsdesk
Pacira BioSciences Sees FY2025 Sales $725.000...
Benzinga Newsdesk
Pacira BioSciences Q4 Adj $0.91 Beats $0.84 E...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2025
Benzinga Insights

Friday, February 14, 2025

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
Vandana Singh

Tuesday, February 11, 2025

Best Value Stocks To Buy For February 11th
Zacks

Thursday, January 30, 2025

What 8 Analyst Ratings Have To Say About Pacira BioSciences
Benzinga Insights
Truist Securities Upgrades Pacira BioSciences...
Benzinga Newsdesk
Pacira Announces That Laura Brege Has Been Ap...
Benzinga Newsdesk

Tuesday, January 14, 2025

RBC Capital Reiterates Sector Perform on Paci...
Benzinga Newsdesk

Monday, January 13, 2025

6 Analysts Assess Pacira BioSciences: What You Need To Know
Benzinga Insights
Needham Maintains Buy on Pacira BioSciences, ...
Benzinga Newsdesk

Friday, January 10, 2025

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Pacira Biosciences shares are trading higher ...
Benzinga Newsdesk
Pacira Reports Prelim. 2024 Revenue Of $710M ...
Benzinga Newsdesk

Tuesday, January 07, 2025

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain
Vandana Singh
Pacira Biosciences shares are trading higher ...
Benzinga Newsdesk
Pacira BioSciences Receives FDA 510k Clearanc...
Benzinga Newsdesk

Wednesday, December 04, 2024

Decoding 6 Analyst Evaluations For Pacira BioSciences
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Pacira ...
Benzinga Newsdesk

Tuesday, December 03, 2024

Pacira Biosciences Received U.S. Patent No. 1...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved